AAAAAA
Results: 26-50/77
Authors:
van den Ouden, D
Schroder, FH
Citation: D. Van Den Ouden et Fh. Schroder, Management of locally advanced prostate cancer - 1. Staging, natural history, and results of radical surgery, WORLD J URO, 18(3), 2000, pp. 194-203
Authors:
Schroder, FH
van den Ouden, D
Citation: Fh. Schroder et D. Van Den Ouden, Management of locally advanced prostate cancer - 2. Radiotherapy, neoadjuvant endocrine treatment, update 1997-1999, WORLD J URO, 18(3), 2000, pp. 204-215
Authors:
van Brussel, JP
Busstra, MB
Lang, MS
Catsburg, T
Schroder, FH
Mickisch, GH
Citation: Jp. Van Brussel et al., A phase II study of temozolomide in hormone-refractory prostate cancer, CANC CHEMOT, 45(6), 2000, pp. 509-512
Authors:
Bosch, JLHR
Klijn, AJ
Schroder, FH
Hop, WCJ
Citation: Jlhr. Bosch et al., The artificial urinary sphincter in 86 patients with intrinsic sphincter deficiency: Satisfactory actuarial adequate function rates, EUR UROL, 38(2), 2000, pp. 156-160
Authors:
de Water, R
Noordermeer, C
Houtsmuller, AB
Nigg, AL
Stijnen, T
Schroder, FH
Kok, DJ
Citation: R. De Water et al., Role of macrophages in nephrolithiasis in rats: An analysis of the renal interstitium, AM J KIDNEY, 36(3), 2000, pp. 615-625
Authors:
Schroder, FH
Alexander, FE
Bangma, CH
Hugosson, J
Smith, DS
Citation: Fh. Schroder et al., Screening and early detection of prostate cancer, PROSTATE, 44(3), 2000, pp. 255-263
Authors:
Schroder, FH
Kranse, R
Barbet, N
Hop, WCJ
Kandra, A
Lassus, M
Citation: Fh. Schroder et al., Prostate-specific antigen: A surrogate endpoint for screening new agents against prostate cancer?, PROSTATE, 42(2), 2000, pp. 107-115
Authors:
Jongsma, J
Oomen, MHA
Noordzij, MA
Romijn, JC
van der Kwast, TH
Schroder, FH
van Steenbrugge, GJ
Citation: J. Jongsma et al., Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines, PROSTATE, 42(1), 2000, pp. 34-44
Authors:
Schroder, FH
Citation: Fh. Schroder, Endocrine treatment of prostate cancer, PROSTATE, 2000, pp. 1-1
Authors:
Schroder, FH
Citation: Fh. Schroder, Endocrine treatment: Expected duration stage by stage, PROSTATE, 2000, pp. 26-31
Authors:
Dohle, GR
Schroder, FH
Citation: Gr. Dohle et Fh. Schroder, Ultrasonographic assessment of the scrotum, LANCET, 356(9242), 2000, pp. 1625-1626
Authors:
Dalesio, O
van Tinteren, H
Peto, R
Clarke, M
Schroder, FH
Citation: O. Dalesio et al., Androgen blockade in prostate cancer - Authors' reply, LANCET, 356(9226), 2000, pp. 341-342
Authors:
Dalesio, O
van Tinteren, H
Clarke, M
Peto, R
Schroder, FH
Dechering, I
Evans, V
Godwin, J
Blumenstein, BA
Crawford, ED
Denis, L
Hall, R
Hill, C
Iversen, P
Shipley, WU
Soloway, M
Sylvester, R
Citation: O. Dalesio et al., Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials, LANCET, 355(9214), 2000, pp. 1491-1498
Authors:
Vis, AN
Boerma, MO
Ciatto, S
Hoedemaeker, RF
Schroder, FH
van der Kwast, TH
Citation: An. Vis et al., Detection of prostate cancer: A comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy, UROLOGY, 56(4), 2000, pp. 617-621
Authors:
Schulman, CC
Zlotta, AR
Denis, L
Schroder, FH
Sakr, WA
Citation: Cc. Schulman et al., Prevention of prostate cancer, SC J UROL N, 34, 2000, pp. 50-61
Authors:
Schroder, FH
Citation: Fh. Schroder, Concluding remarks, SC J UROL N, 34, 2000, pp. 230-232
Authors:
Alers, JC
Rochat, J
Krijtenburg, PJ
Hop, WCJ
Kranse, R
Rosenberg, C
Tanke, HJ
Schroder, FH
van Dekken, H
Citation: Jc. Alers et al., Identification of genetic markers for prostatic cancer progression, LAB INV, 80(6), 2000, pp. 931-942
Authors:
Vis, AN
Noordzij, MA
Fitoz, K
Wildhagen, MF
Schroder, FH
van der Kwast, TH
Citation: An. Vis et al., Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer, J UROL, 164(6), 2000, pp. 2156-2161
Authors:
Beemsterboer, PMM
de Koning, HJ
Kranse, R
Trienekens, PH
van der Maas, PJ
Schroder, FH
Citation: Pmm. Beemsterboer et al., Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam, J UROL, 164(4), 2000, pp. 1216-1220
Authors:
Hoedemaeker, RF
Rietbergen, JBW
Kranse, R
Schroder, FH
van der Kwast, TH
Citation: Rf. Hoedemaeker et al., Histopathological prostate cancer characteristics at radical prostatectomyafter population based screening, J UROL, 164(2), 2000, pp. 411-415
Authors:
Schroder, FH
van der Cruijsen-Koeter, I
de Koning, HJ
Vis, AN
Hoedemaeker, RF
Kranse, R
Citation: Fh. Schroder et al., Prostate cancer detection at low prostate specific antigen, J UROL, 163(3), 2000, pp. 806-811
Authors:
Jongsma, J
Oomen, MH
Noordzij, MA
Van Weerden, WM
Martens, GJM
van der Kwast, TH
Schroder, FH
van Steenbrugge, GJ
Citation: J. Jongsma et al., Androgen deprivation of the prohormone convertase-310 human prostate cancer model system induces neuroendocrine differentiation, CANCER RES, 60(3), 2000, pp. 741-748
Authors:
Schroder, FH
Collette, L
de Reijke, TM
Whelan, P
Citation: Fh. Schroder et al., Prostate cancer treated by anti-androgens: is sexual function preserved?, BR J CANC, 82(2), 2000, pp. 283-290
Authors:
Schroder, FH
Citation: Fh. Schroder, Early detection and treatment of prostate cancer: a road to patient benefit?, PROG ANTI C, 4, 2000, pp. 163-169
Authors:
Schroder, FH
Citation: Fh. Schroder, Lest we abandon digital rectal examination as a screening test for prostate cancer, J NAT CANC, 91(15), 1999, pp. 1331-1332